239 related articles for article (PubMed ID: 26466221)
1. Use of statins and the incidence of type 2 diabetes mellitus.
Bernardi A; Rocha VZ; Faria-Neto JR
Rev Assoc Med Bras (1992); 2015 Aug; 61(4):375-80. PubMed ID: 26466221
[TBL] [Abstract][Full Text] [Related]
2. Diabetogenic Action of Statins: Mechanisms.
Carmena R; Betteridge DJ
Curr Atheroscler Rep; 2019 Apr; 21(6):23. PubMed ID: 31037345
[TBL] [Abstract][Full Text] [Related]
3. Statin-associated incident diabetes: a literature review.
Park ZH; Juska A; Dyakov D; Patel RV
Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis and management of the diabetogenic effect of statins: a role for adiponectin and coenzyme Q10?
Chan DC; Pang J; Watts GF
Curr Atheroscler Rep; 2015 Jan; 17(1):472. PubMed ID: 25398645
[TBL] [Abstract][Full Text] [Related]
5. Primary prevention with statins and incident diabetes in hypertensive patients at high cardiovascular risk.
Izzo R; de Simone G; Trimarco V; Giudice R; De Marco M; Di Renzo G; De Luca N; Trimarco B
Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1101-6. PubMed ID: 23419735
[TBL] [Abstract][Full Text] [Related]
6. Diabetes Secondary to Treatment with Statins.
Laakso M; Kuusisto J
Curr Diab Rep; 2017 Feb; 17(2):10. PubMed ID: 28155189
[TBL] [Abstract][Full Text] [Related]
7. Statin therapy and related risk of new-onset type 2 diabetes mellitus.
Ruscica M; Macchi C; Morlotti B; Sirtori CR; Magni P
Eur J Intern Med; 2014 Jun; 25(5):401-6. PubMed ID: 24685426
[TBL] [Abstract][Full Text] [Related]
8. [Statins diabetogenicity: are all the same? state of art].
Rius Tarruella J; Millán Núñez-Cortés J; Pedro-Botet J; Pintó Sala X
Clin Investig Arterioscler; 2015; 27(3):148-58. PubMed ID: 25835612
[TBL] [Abstract][Full Text] [Related]
9. Statin Use, Diabetes Incidence and Overall Mortality in Normoglycemic and Impaired Fasting Glucose Patients.
Castro MR; Simon G; Cha SS; Yawn BP; Melton LJ; Caraballo PJ
J Gen Intern Med; 2016 May; 31(5):502-8. PubMed ID: 26850412
[TBL] [Abstract][Full Text] [Related]
10. Is statin-induced diabetes clinically relevant? A comprehensive review of the literature.
Bell DS; DiNicolantonio JJ; O'Keefe JH
Diabetes Obes Metab; 2014 Aug; 16(8):689-94. PubMed ID: 24373206
[TBL] [Abstract][Full Text] [Related]
11. Statins and diabetes risk: how real is it and what are the mechanisms?
Robinson JG
Curr Opin Lipidol; 2015 Jun; 26(3):228-35. PubMed ID: 25887679
[TBL] [Abstract][Full Text] [Related]
12. The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practice.
Sattar NA; Ginsberg H; Ray K; Chapman MJ; Arca M; Averna M; Betteridge DJ; Bhatnagar D; Bilianou E; Carmena R; Ceška R; Corsini A; Erbel R; Flynn PD; Garcia-Moll X; Gumprecht J; Ishibashi S; Jambart S; Kastelein JJ; Maher V; da Silva PM; Masana L; Odawara M; Pedersen TR; Rotella CM; Salti I; Teramoto T; Tokgozoglu L; Toth PP; Valensi P; Vergès B
Atheroscler Suppl; 2014 Jun; 15(1):1-15. PubMed ID: 24840509
[TBL] [Abstract][Full Text] [Related]
13. Statin diabetogenicity: guidance for clinicians.
Ray K
Cardiovasc Diabetol; 2013; 12 Suppl 1(Suppl 1):S3. PubMed ID: 23819776
[TBL] [Abstract][Full Text] [Related]
14. Statins and their increased risk of inducing diabetes.
Agouridis AP; Kostapanos MS; Elisaf MS
Expert Opin Drug Saf; 2015; 14(12):1835-44. PubMed ID: 26437128
[TBL] [Abstract][Full Text] [Related]
15. [STATINS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE AND DIABETES INCIDENCE--THE BENEFITS VERSUS THE RISKS].
Lavie G; Cohen S
Harefuah; 2015 Jun; 154(6):382-6, 404. PubMed ID: 26281083
[TBL] [Abstract][Full Text] [Related]
16. How do we know that statins are diabetogenic, and why? Is it an important issue in the clinical practice?
Cybulska B; Kłosiewicz-Latoszek L
Kardiol Pol; 2018; 76(8):1217-1223. PubMed ID: 30067279
[TBL] [Abstract][Full Text] [Related]
17. Is diabetes the cost to pay for a greater cardiovascular prevention?
Rizzo M; Spinas GA; Rini GB; Berneis K
Int J Cardiol; 2010 Oct; 144(2):309-10. PubMed ID: 19297038
[TBL] [Abstract][Full Text] [Related]
18. The controversies of statin therapy: weighing the evidence.
Jukema JW; Cannon CP; de Craen AJ; Westendorp RG; Trompet S
J Am Coll Cardiol; 2012 Sep; 60(10):875-81. PubMed ID: 22902202
[TBL] [Abstract][Full Text] [Related]
19. Do statins increase the risk of diabetes or is it guilt by association?
Mogadam M
Curr Opin Endocrinol Diabetes Obes; 2014 Apr; 21(2):140-5. PubMed ID: 24569555
[TBL] [Abstract][Full Text] [Related]
20. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]